Tyra BiosciencesTYRA +3.07%28 Market Cap is $1,895.92 Mil as of Jun. 26, 2026. GuruFocus rates TYRA with a GF Score™ of 28/100. The stock has 2 warning signs investors should review. Among 1,431 Biotechnology companies, Tyra Biosciences ranks better than 87.14% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Tyra Biosciences's share price for the quarter that ended in Mar. 2026 was $38.3. Tyra Biosciences's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 59.47 Mil. Therefore, Tyra Biosciences's market cap for the quarter that ended in Mar. 2026 was $2,277.70 Mil.
Tyra Biosciences's quarterly market cap
increased
from Sep. 2025 ($745.92 Mil) to Dec. 2025 ($1,411.93 Mil) and
increased
from Dec. 2025 ($1,411.93 Mil) to Mar. 2026 ($2,277.70 Mil).
Tyra Biosciences's annual market cap
increased
from Dec. 2023 ($595.90 Mil) to Dec. 2024 ($705.43 Mil) and
increased
from Dec. 2024 ($705.43 Mil) to Dec. 2025 ($1,411.93 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Tyra Biosciences's Enterprise Value for Today is $1,518.15 Mil.
Tyra Biosciences (NAS:TYRA) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Tyra Biosciences Market Cap Related Terms
Tyra Biosciences Market Cap Historical Data
* Premium members only.
The historical data trend for Tyra Biosciences's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Tyra Biosciences's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tyra Biosciences Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Tyra Biosciences's Market Cap distribution charts can be found below:
* The bar in red indicates where Tyra Biosciences's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Tyra Biosciences's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tyra Biosciences (TYRA) has a Market Cap of $1,895.92 Mil as of Jun. 26, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Tyra Biosciences and its competitors. According to the industry distribution chart, Tyra Biosciences ranks #184 out of 1431 companies in the Biotechnology industry, placing it in the top 12.9%.
Is Tyra Biosciences' Market Cap too high?
Tyra Biosciences' current Market Cap is $1,895.92 Mil. The Biotechnology industry median Market Cap is 113.83. Tyra Biosciences' value of $1,895.92 Mil is 1565.6% above this industry median. Based on the distribution chart, Tyra Biosciences ranks #184 out of 1431 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Tyra Biosciences has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does Tyra Biosciences' Market Cap compare to ZLAB and OCUL?
According to the Biotechnology industry distribution chart, Tyra Biosciences ranks #184 out of 1431 companies for Market Cap. This places Tyra Biosciences in the top 13% of its industry — outperforming the majority of peers. The industry median Market Cap is 113.83. Tyra Biosciences' value of $1,895.92 Mil is 1565.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 113.83, based on 1,431 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Tyra Biosciences's current Market Cap of $1,895.92 Mil is 1565.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Tyra Biosciences and its competitors. For the Biotechnology industry, the median Market Cap is 113.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tyra Biosciences's current Market Cap is $1,895.92 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tyra Biosciences stock overvalued right now?
Tyra Biosciences (TYRA) has a current Market Cap of $1,895.92 Mil. The current Market Cap is $1,895.92 Mil and 1565.6% above the Biotechnology industry median of 113.83. Tyra Biosciences' overall GF Score™ is 28/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Tyra Biosciences (TYRA), the current Market Cap is $1,895.92 Mil as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines for large opportunities in targeted oncology and genetically defined conditions, harnessing the power of Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are FGFR3, FGFR4/3, and FGFR1/2/3: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.
28GF Score
Get the complete analysis for TYRA
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TYRA has been successfully added to your 
